Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13

Orthofix Medical, Inc.

Orthofix Medical, Inc.

OFIX

0.00

Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ: OFIX) with a Buy and lowers the price target from $18 to $13.